Stapokibart shows promise in reducing nasal congestion in seasonal allergy patients, study finds Post author: Post published:February 9, 2024 Post category:uncategorized The efficacy and safety of stapokibart as an in patients with seasonal allergic rhinitis (SAR). You Might Also Like Polypills prove effective in reducing cardiovascular disease and mortality March 29, 2024 Proximity and health of grandparents influence mothers’ antidepressant use February 15, 2024 Aggressive blood pressure management offers greater health benefits August 19, 2025